SINTX Technologies, Inc. SINT

Q3 FY2026 · ended Sep 30, 2026 · Revenue $2.19M, +952.9% YoY · Filed Nov 5, 2026

SINTX Technologies, Inc. (SINT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $2.2 million and a net loss of $1.6 million. Free cash flow was -$1.5 million. As of Sep 30, 2026 it held $2.0 million in cash and investments and $3.0 million in total debt.

Revenue
$2.19M
+952.9% vs year-ago quarter
Net income
$-1.59M
+54.9% vs year-ago quarter
Operating cash flow
$-1.37M
+45.6% vs year-ago quarter
Free cash flow
$-1.51M
+41.8% vs year-ago quarter
EPS
$-0.24
+93.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
7.56M
+96.2% vs year-ago quarter
Net cash
$-999,000
Q3 FY2026
Operating margin
-303.4%
TTM

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SINT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1269026
Former names
AMEDICA CORP (until Oct 5, 2018); AMEDICA Corp (until Oct 5, 2018)

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Revenue
$2.2M
$452,000
$380,000
$290,000
$208,000
Operating income
-$1.6M
-$2.9M
-$3.2M
-$2.3M
-$3.4M
Net income
-$1.6M
-$2.7M
-$2.8M
-$2.2M
-$3.5M
Diluted EPS
-$0.24
-$0.75
-$0.70
-$0.58
-$3.46
Operating cash flow
-$1.4M
-$2.8M
-$2.5M
-$2.3M
-$2.5M
Free cash flow
-$1.5M
-$2.9M
-$2.5M
-$2.4M
-$2.6M
Total assets
$8.9M
$10.4M
$7.8M
$9.5M
$11.4M
Total liabilities
$5.5M
$5.6M
$6.9M
$6.6M
$7.3M
Stockholders' equity
$3.4M
$4.8M
$904,000
$2.9M
$4.1M
Cash and investments
$2.0M
$3.6M
$1.9M
$4.1M
$6.2M
Total debt
$3.0M
$3.2M
$3.3M
$3.2M
$3.4M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Other events
Oct 9, 2026 Oct 8, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Oct 1, 2026 Oct 1, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 13, 2026 Aug 12, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2026 Aug 11, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.